After decades of neglect, malnutrition-related diabetes, or type 5, is finally getting the research, recognition, and ...

Objective: Health care resource utilization (HCRU) and cost among Medicaid patients with serious mental illness (SMI) were ...

AJMC: 64% of patients who responded to pCR skipped traditional chemotherapy entirely, and 97% avoided anthracyclines. For patients and oncologists, what does that mean in practice, and how do you ...

Mark Malesker, PharmD, discusses the clinical evidence, drug interaction risks, and formulary challenges surrounding cannabinoid use for sleep disorders.

Permanent rulemaking would replace IPAY 2026–2028 guidance, enabling predictable annual negotiations of up to 20 drugs and defined manufacturer agreement and renegotiation requirements. Formularies ...

New factor XIa inhibitors cut recurrent non-cardioembolic stroke without extra bleeding—plus what milvexian and abilacimab trials reveal. In this installment of this series, ‘The Future of Factor XIa ...

In this episode titled, 'Understanding Neuroendocrine Carcinomas: Definitions, Types, and Clinical Presentation,' Ryan Haumschil ...

Specialty pharmacies reduce administrative burden and total cost of care as advanced therapies move to community sites, Fran ...

Melanocyte melanin synthesis creates constitutive ROS vulnerability, and impaired Nrf2-mediated antioxidant responses enable ...

To mitigate this risk, the Chaparro recommends pairing pharmacologic therapy with light resistance or weight training and ...

For Europe to remain an attractive site for phase 3 research, he argued, regulatory predictability is paramount. El-Galaly ...

Shannon L. Maude, MD, PhD, highlighted promising long-term disease-free survival and MRD negativity with tisagenleucel in ...